Public Hearing Regarding Section 301 Investigation of Germany’s Persistent Underpayment for Innovative Pharmaceutical Products

The Office of the United States Trade Representative announced a public hearing concerning the Section 301 investigation into Germany's practices regarding underpayment for innovative pharmaceutical products. The hearing will take place on September 22, 2026, at the U.S. International Trade Commission in Washington, D.C.